ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Dec 16, 2022 11:00 JST
Source:
Olympus
Olympus Named to Dow Jones Sustainability World Index for Two Consecutive Years
TOKYO, Dec 16, 2022 - (JCN Newswire) - Olympus Corporation (Olympus), a global medtech company committed to making people's lives healthier, safer and more fulfilling, announced that it has been selected for inclusion in the 2022 Dow Jones Sustainability World Index (DJSI World) and the 2022 Dow Jones Sustainability Asia Pacific Index (DJSI Asia Pacific), both among the most globally recognized corporate sustainability indices. Olympus has been named to the DJSI World for two consecutive years and DJSI Asia Pacific for four.
The Dow Jones Sustainability Indices (DJSI) are corporate sustainability evaluation indices for environmental, social, and governance (ESG) investment. Jointly developed by S&P Dow Jones Indices and RobecoSAM, the DJSI track the financial performances of leading companies according to ESG criteria. These indices are updated annually to include companies with excellent corporate sustainability practices.
In 2022, 332 companies were selected as DJSI World members from approximately 3,500 companies worldwide in 61 industry sectors, and 156 companies were selected as DJSI Asia Pacific members from approximately 600 companies assessed in the region. Olympus is one of only 8 out of 64 companies to have been included in the DJSI World Health Care Equipment & Supplies sector. The company's scores on Access to Healthcare, Talent Attraction & Retention, Tax Strategy, Environmental Policy & Management Systems were of particular note, being not only highly rated, but having also been improved over last year's scores. In addition to the DJSI World and Asia Pacific, Olympus was also named to the FTSE4Good Index Series and FTSE Blossom Japan Index.
Stefan Kaufmann; Director, Executive Officer, and Chief Administrative Officer of Olympus, stated: "It is a great honor for Olympus to again be selected for the DJSI World and Asia Pacific. In order to realize Our Purpose of Making people's lives healthier, safer and more fulfilling, we have taken various initiatives to contribute to society, positioning ESG as one of the most important strategic pillars in our Corporate Strategy. We are proud to be included in the DJSI World and Asia Pacific for consecutive years as evidence of our continuous evolution as well as our high reputation in ESG from stakeholders. We will further accelerate our efforts to realize a sustainable society."
Based on Our Purpose, Olympus believes that the sustainability of a company will be recognized primarily by meeting the demands and expectations of society and fulfilling responsibilities through dialogue with all stakeholders. The company will continue to contribute to creating a sustainable society by actively engaging in activities that incorporate ESG perspectives to fulfill its corporate social responsibilities on a global scale.
For more information on Olympus' ESG initiatives, please refer to its Integrated Report 2022[1] and the Sustainability page on its website[2].
[1]
https://www.olympus-global.com/ir/data/integratedreport/2022.html?page=ir
[2]
https://www.olympus-global.com/csr/
About Olympus
Olympus is passionate about creating customer-driven solutions for the medical, life sciences, and industrial equipment industries. For more than 100 years, Olympus has focused on making people's lives healthier, safer and more fulfilling by helping to detect, prevent, and treat disease; furthering scientific research; and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 30,000 employees worldwide in nearly 40 countries and regions. For more information, visit www.olympus-global.com and follow our global Twitter account: @Olympus_Corp (
https://twitter.com/olympus_corp
).
Media contact:
Mieko Yamada
Global-Public_Relations@olympus.com
Olympus Corp [TYO: 7733] [ADR: OCPNY] [GDR: OLYS]
https://www.olympus-global.com
Source: Olympus
Sectors: Environment, ESG, BioTech, Healthcare & Pharm, Funds & Equities, MedTech
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
All-New Triton Wins Special Award at the RJC Car of the Year for 2025
Nov 12, 2024 22:09 JST
Toyota: HySE to participate in the Dakar 2025 "Mission 1000 ACT2" with the HySE-X2, to tackle further technical challenges
Nov 12, 2024 20:04 JST
NEC participates in COP29 climate change conference
Nov 12, 2024 19:25 JST
JA Mitsui Leasing and Fujitsu collaborate on simulation-driven field trials to optimize commercial EV adoption and drive decarbonization
Nov 12, 2024 13:57 JST
Macnica publishes Integrated Report on the theme of 'An Introductory Guide to Macnica's Mechanism'
Nov 12, 2024 13:00 JST
Hitachi: Established the Open Source Program Office (OSPO) to Globally Lead the Strategic Utilization of OSS
Nov 11, 2024 10:31 JST
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
Nov 08, 2024 10:31 JST
Hitachi High-Tech and University of Tokyo Promote Joint Research for the Practical Application of High-resolution Laser-PEEM in the Semiconductor Field
Nov 07, 2024 18:19 JST
Mitsubishi Motors Acquires Its Own Shares from Nissan
Nov 07, 2024 17:20 JST
Honda Signs Sponsorship Agreement to Provide Electrified Vehicles at World Athletics Championships Tokyo 25
Nov 07, 2024 17:10 JST
Home of Fujitsu joint conservation project designated as first Nationally Certified Sustainably Managed Natural Site in Okinawa
Nov 07, 2024 14:51 JST
NEC and NEC Bio publish foundational work on T Cell Receptor engineering using proprietary generative AI at the Society for Immunotherapy of Cancer annual meeting
Nov 07, 2024 11:40 JST
Anime Tokyo Station 1st Anniversary Event: Celebrating one year since the opening of the new hub for sharing Japanese anime
Nov 07, 2024 11:00 JST
57% of Banking Executives Struggle with Data Silos, Blocking AI-Driven Personalization, CleverTap's New Report Highlights
Nov 06, 2024 15:30 JST
Honda Unveils Electric Motorcycle Concept Models "EV Fun Concept" and "EV Urban Concept" at EICMA 2024
Nov 06, 2024 14:15 JST
Yoshimoto Kogyo and Mitsubishi Corporation have signed a business partnership agreement for co-creation of business using "laughter"
Nov 06, 2024 11:51 JST
Honda to Begin European Verification Test of Battery Sharing Service with GoCimo
Nov 06, 2024 10:39 JST
Honda Unveils World's First and New V3 Engine with Electrical- Compressor at EICMA 2024
Nov 06, 2024 09:03 JST
Victory and world title for TOYOTA GAZOO Racing
Nov 05, 2024 17:59 JST
Tokyo Stock Exchange and Fujitsu announce renewal of cash equity trading system 'arrowhead4.0'
Nov 05, 2024 17:13 JST
More Latest Release >>
Related Release
Olympus Launches VISERA S, a New Imaging Platform
9/30/2024 3:00:00 PM JST
Olympus Launches New 4K Camera Head for Urological Endoscopy
9/20/2024 3:00:00 PM JST
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
6/12/2024 11:00:00 AM JST
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
3/27/2024 3:00:00 PM JST
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
1/24/2024 3:00:00 PM JST
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
12/11/2023 11:00:00 AM JST
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
12/7/2023 11:00:00 AM JST
Olympus's Net-Zero Targets Approved by SBTi
11/30/2023 11:00:00 AM JST
Olympus Names Dr. John de Csepel as Chief Medical Officer
10/6/2023 9:00:00 PM JST
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
7/20/2023 11:00:00 AM JST
More Press release >>